can you take ibuprofen with bpc 157 i BPC-157 and TB-500: Injury Healing Peptides BPC-157 Injury Recovery: Weeks 1-12

The safety and effectiveness of EGRIFTA WR (11.6 mg/vial formulation) has been established based on adequate and well controlled studies with EGRIFTA (1 mg/vial formulation), as well as a demonstration of comparable bioavailability between the 1.28 mg EGRIFTA WR dose (11.6 mg/vial formulation) and the 2 mg EGRIFTA dose (1 mg/vial formulation) [see Clinical Pharmacology (12.3)]

Injecting untested, unregulated peptides is, at best, a large waste of money and, at worst, a path to long-term side effects that we do not yet understand

Its becoming more popular because it lasts longer in the body

However, palpitations can also come from common arrhythmias that have nothing to do with B12

BPC-157 is supplied strictly for laboratory research use only